Advertisement
News
Advertisement

Genzyme-marketed thyroid cancer test licensed in NY

Wed, 08/29/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

A New York City hospital specializing in cancer will be the first in that state to offer a thyroid cancer test being marketed by Genzyme Corp., owned by French drug maker Sanofi (NYSE: SNY), now that the test has been licensed by the state.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading